Ammann Sandra, Schulz Ansgar, Krägeloh-Mann Ingeborg, Dieckmann Nele M G, Niethammer Klaus, Fuchs Sebastian, Eckl Katja Martina, Plank Roswitha, Werner Roland, Altmüller Janine, Thiele Holger, Nürnberg Peter, Bank Julia, Strauss Anne, von Bernuth Horst, Zur Stadt Udo, Grieve Samantha, Griffiths Gillian M, Lehmberg Kai, Hennies Hans Christian, Ehl Stephan
Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany; Faculty of Biology, University Freiburg, Freiburg, Germany;
Department of Pediatrics, University Medical Center Ulm, Ulm, Germany;
Blood. 2016 Feb 25;127(8):997-1006. doi: 10.1182/blood-2015-09-671636. Epub 2016 Jan 7.
Genetic disorders affecting biogenesis and transport of lysosome-related organelles are heterogeneous diseases frequently associated with albinism. We studied a patient with albinism, neutropenia, immunodeficiency, neurodevelopmental delay, generalized seizures, and impaired hearing but with no mutation in genes so far associated with albinism and immunodeficiency. Whole exome sequencing identified a homozygous mutation in AP3D1 that leads to destabilization of the adaptor protein 3 (AP3) complex. AP3 complex formation and the degranulation defect in patient T cells were restored by retroviral reconstitution. A previously described hypopigmented mouse mutant with an Ap3d1 null mutation (mocha strain) shares the neurologic phenotype with our patient and shows a platelet storage pool deficiency characteristic of Hermansky-Pudlak syndrome (HPS) that was not studied in our patient because of a lack of bleeding. HPS2 caused by mutations in AP3B1A leads to a highly overlapping phenotype without the neurologic symptoms. The AP3 complex exists in a ubiquitous and a neuronal form. AP3D1 codes for the AP3δ subunit of the complex, which is essential for both forms. In contrast, the AP3β3A subunit, affected in HPS2 patients, is substituted by AP3β3B in the neuron-specific heterotetramer. AP3δ deficiency thus causes a severe neurologic disorder with immunodeficiency and albinism that we propose to classify as HPS10.
影响溶酶体相关细胞器生物发生和转运的遗传性疾病是一类异质性疾病,常与白化病相关。我们研究了一名患有白化病、中性粒细胞减少、免疫缺陷、神经发育迟缓、全身性癫痫发作和听力受损的患者,但目前与白化病和免疫缺陷相关的基因均未发现突变。全外显子测序在AP3D1基因中发现了一个纯合突变,该突变导致衔接蛋白3(AP3)复合体不稳定。通过逆转录病毒重组可恢复患者T细胞中的AP3复合体形成和脱颗粒缺陷。先前描述的一种具有Ap3d1无效突变的色素减退小鼠突变体(摩卡品系)与我们的患者具有相同的神经学表型,并表现出Hermansky-Pudlak综合征(HPS)特征性的血小板储存池缺陷,由于我们的患者没有出血症状,因此未对其进行研究。由AP3B1A基因突变引起的HPS2会导致高度重叠的表型,但没有神经学症状。AP3复合体以普遍存在的形式和神经元形式存在。AP3D1编码该复合体的AP3δ亚基,这两种形式都必不可少。相比之下,在HPS2患者中受影响的AP3β3A亚基在神经元特异性异源四聚体中被AP3β3B取代。因此,AP3δ缺陷会导致一种严重的神经疾病,伴有免疫缺陷和白化病,我们建议将其归类为HPS10。